M-PTCy vs BuCy in Haploidentical HSCT for Acute Leukemia
Status:
Recruiting
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
This study intends to evaluate the efficiency and safety of M-PTCy as conditioning regimen in
Haploidentical HSCT for Acute Leukemia, so as to provide a new conditioning regimen for
allogeneic hematopoietic cell transplantation.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University